Next Article in Journal
Linoleic Acid Attenuates the Toxic Dose of Bupivacaine-Mediated Reduction of Vasodilation Evoked by the Activation of Adenosine Triphosphate-Sensitive Potassium Channels
Next Article in Special Issue
Hedgehog Signaling Pathway and Autophagy in Cancer
Previous Article in Journal
Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 7
10.3390/ijms19071875
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

FGF Family: From Drug Development to Clinical Application

by
Qi Hui
1,
Zi Jin
1,
Xiaokun Li
1,2,
Changxiao Liu
1,3 and
Xiaojie Wang
1,2,*
1
School of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China
2
Key Laboratory Biotechnology Pharmaceutical Engineering, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China
3
State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, 308 Anshan West Road, Tianjin 300193, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 1875; https://doi.org/10.3390/ijms19071875
Submission received: 6 May 2018 / Revised: 17 June 2018 / Accepted: 21 June 2018 / Published: 26 June 2018
(This article belongs to the Special Issue Hedgehog Signaling)
Browse Figures
Versions Notes

Abstract

Fibroblast growth factor (FGF) belongs to a large family of growth factors. FGFs use paracrine or endocrine signaling to mediate a myriad of biological and pathophysiological process, including angiogenesis, wound healing, embryonic development, and metabolism regulation. FGF drugs for the treatment of burn and ulcer wounds are now available. The recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in maintaining homeostasis of bile acid, glucose, and phosphate further extended the activity profile of this family. Here, the applications of recombinant FGFs for the treatment of wounds, diabetes, hypophosphatemia, the development of FGF receptor inhibitors as anti-neoplastic drugs, and the achievements of basic research and applications of FGFs in China are reviewed.
Keywords: fibroblast growth factor; wound healing; metabolic regulation; fibroblast growth factor receptor inhibitor; drug development; clinical application fibroblast growth factor; wound healing; metabolic regulation; fibroblast growth factor receptor inhibitor; drug development; clinical application

Share and Cite

MDPI and ACS Style

Hui, Q.; Jin, Z.; Li, X.; Liu, C.; Wang, X. FGF Family: From Drug Development to Clinical Application. Int. J. Mol. Sci. 2018, 19, 1875. https://doi.org/10.3390/ijms19071875

AMA Style

Hui Q, Jin Z, Li X, Liu C, Wang X. FGF Family: From Drug Development to Clinical Application. International Journal of Molecular Sciences. 2018; 19(7):1875. https://doi.org/10.3390/ijms19071875

Chicago/Turabian Style

Hui, Qi, Zi Jin, Xiaokun Li, Changxiao Liu, and Xiaojie Wang. 2018. "FGF Family: From Drug Development to Clinical Application" International Journal of Molecular Sciences 19, no. 7: 1875. https://doi.org/10.3390/ijms19071875

APA Style

Hui, Q., Jin, Z., Li, X., Liu, C., & Wang, X. (2018). FGF Family: From Drug Development to Clinical Application. International Journal of Molecular Sciences, 19(7), 1875. https://doi.org/10.3390/ijms19071875

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop